Gross product sales — Total Revenues
Bristol-Myers Squibb Gross product sales — Total Revenues increased by 1.4% to $22.49B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.0%, from $21.22B to $22.49B. Over 3 years (FY 2021 to FY 2024), Gross product sales — Total Revenues shows an upward trend with a 7.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates strong market demand and successful commercialization of the drug portfolio, while a decrease may signal competitive pressure, loss of patent exclusivity, or declining market share. Monitoring the gap between gross sales and net revenue helps identify trends in pricing pressure and payer negotiations.
Detailed definition
This metric represents the total gross revenue generated from the sale of pharmaceutical products before accounting for...
Peer comparison
Most large-cap pharmaceutical companies report gross-to-net adjustments, making this a standard starting point for evaluating top-line performance across the industry.
bmy_segment_gross_product_sales_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $16.97B | $16.97B | $16.97B | $16.65B | $17.30B | $17.61B | $18.08B | $17.29B | $18.11B | $18.65B | $19.63B | $19.30B | $20.78B | $21.22B | $22.37B | $19.87B | $22.18B | $22.49B |
| QoQ Change | — | +0.0% | +0.0% | -1.9% | +3.9% | +1.8% | +2.7% | -4.4% | +4.8% | +3.0% | +5.3% | -1.7% | +7.7% | +2.1% | +5.4% | -11.2% | +11.6% | +1.4% |
| YoY Change | — | — | — | — | +1.9% | +3.7% | +6.5% | +3.8% | +4.7% | +5.9% | +8.6% | +11.6% | +14.7% | +13.8% | +14.0% | +3.0% | +6.7% | +6.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's gross product sales — total revenues?
- Bristol-Myers Squibb (BMY) reported gross product sales — total revenues of $22.49B in Q3 2025.
- How has Bristol-Myers Squibb's gross product sales — total revenues changed year-over-year?
- Bristol-Myers Squibb's gross product sales — total revenues increased by 6.0% year-over-year, from $21.22B to $22.49B.
- What is the long-term trend for Bristol-Myers Squibb's gross product sales — total revenues?
- Over 3 years (2021 to 2024), Bristol-Myers Squibb's gross product sales — total revenues has grown at a 7.2% compound annual growth rate (CAGR), from $67.90B to $83.67B.
- What does gross product sales — total revenues mean?
- The total revenue generated from product sales before subtracting rebates, discounts, and other pricing adjustments.